GeoVax Labs
GOVX
7 hedge funds and large institutions have $619K invested in GeoVax Labs in 2024 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 0 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
40% more funds holding
Funds holding: 5 → 7 (+2)
3.41% less ownership
Funds ownership: 11.1% → 7.68% (-3.4%)
48% less capital inflows, than outflows
Capital inflows: $90.7K | Capital outflows: $173K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$79.1K |
| 2 |
Tower Research Capital (TRC)
New York
|
+$5.27K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$4.22K |
| 4 |
Morgan Stanley
New York
|
+$2.11K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Armistice Capital
New York
|
-$173K |
| 2 |
JP Morgan Chase
New York
|
-$2 |
GOVX Hedge Fund Activity: Q2 2024 in Review
7 of the 6,944 institutional investors tracked by Wall St. Rank reported a position in GeoVax Labs (GOVX) for Q2 2024, worth a combined $619K — up 29% from $481K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new GOVX positions and 0 closed out — a net gain of 2 holders — while 2 added to existing stakes and 1 trimmed.
The largest buyer was Bank of America, opening a new position worth an estimated $79.1K. The largest seller was Armistice Capital, cutting an estimated $173K.
- 7 institutional investors held GeoVax Labs (GOVX) as of Q2 2024, up from 5 in Q1 2024.
- Funds reported $619K of GeoVax Labs stock for Q2 2024, up 29% quarter-over-quarter.
- 2 funds opened new GeoVax Labs positions in Q2 2024 and 0 closed out, a net change of +2 holders.
- The largest GeoVax Labs buyer in Q2 2024 was Bank of America, an estimated $79.1K added.
- The largest GeoVax Labs seller in Q2 2024 was Armistice Capital, an estimated $173K sold.
Based on aggregated 13F filings for Q2 2024.